Business developments - Business developments (Details 5) - CHF (SFr) SFr in Millions |
3 Months Ended | 12 Months Ended | |||
|---|---|---|---|---|---|
Sep. 30, 2021 |
Dec. 31, 2020 |
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
| Subsidiary, Sale of Stock [Line Items] | |||||
| Net revenues | SFr 22,696 | SFr 22,389 | SFr 22,484 | ||
| Total operating expenses | SFr 19,091 | SFr 17,826 | SFr 17,440 | ||
| Allfunds Group [Member] | |||||
| Subsidiary, Sale of Stock [Line Items] | |||||
| Sale of Stock, Description of Transaction | Allfunds Group Credit Suisse holds an equity investment in Allfunds Group following the transfer of the Group’s open architecture investment fund platform Credit Suisse InvestLab to Allfunds Group. On April 23, 2021, Allfunds Group announced a successful initial public offering (IPO) on the Euronext Amsterdam exchange with an initial market capitalization of EUR 7.24 billion on the day of the listing. Net revenues in 2021 pertaining to Allfunds Group included gains of CHF 622 million reflecting share price movements as well as a reduction of the Group’s equity interest from 14.0% to 8.6% as of December 31, 2021. Following the IPO, the Group’s investment in Allfunds Group was reclassified from other investments to trading assets. | ||||
| Subsidiary or Equity Method Investee, Cumulative Percentage Ownership after All Transactions | 8.60% | 14.00% | |||
| Net revenues | SFr 622 | ||||
| Credit Suisse Life and Pensions AG [Member] | |||||
| Subsidiary, Sale of Stock [Line Items] | |||||
| Sale of Stock, Description of Transaction | Credit Suisse Life & Pensions AG In the third quarter of 2021, Credit Suisse Life & Pensions AG was sold to Octium Holdings SA. As a result of the sale, the Group recorded a loss of CHF 42 million, which was reflected in International Wealth Management and Swiss Universal Bank. Related assets and liabilities have been reclassified to held-for-sale until close of this transaction. | ||||
| Net revenues | SFr 42 | ||||
| York Capital Management [Member] | |||||
| Subsidiary, Sale of Stock [Line Items] | |||||
| Net revenues | SFr (113) | SFr (414) | |||